Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Leukemia & Lymphoma
|
April 22, 2024
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with <i>FLT3-</i>mutant acute myeloid leukemia
Jan Philipp Bewersdorf, Kishan K Patel, Rory M Shallis, et al.
Cancer Medicine
|
September 13, 2023
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia
Nikolai A Podoltsev, Rong Wang, Rory M Shallis, et al.
Pharmacology Research & Perspectives
|
November 2, 2024
Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy
Scott F Huntington, Dee Lin, Marie-Hélène Lafeuille, et al.
Leukemia & Lymphoma
|
May 2, 2024
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
Scott F Huntington, Wendy Y Cheng, Eric M Sarpong, et al.
Blood Advances
|
April 21, 2020
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, et al.
Blood Advances
|
July 28, 2025
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML
Abdulrahman Alhajahjeh, Kishan Patel, Nikolai A Podoltsev, et al.
JAMA Network Open
|
June 5, 2023
The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021
Gaurav Goyal, Krystal W Lau, Xiaoliang Wang, et al.
British Journal of Haematology
|
September 22, 2016
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes
Amer M Zeidan, Amy J Davidoff, Jessica B Long, et al.
Leukemia & Lymphoma
|
July 12, 2026
Treatment inequity among older adults with newly diagnosed acute myeloid leukemia ineligible for intensive therapy
Alain Mina, Yanqing Xu, Tatyana A Kapustyan, et al.
Plos One
|
September 14, 2017
Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study
Amer M Zeidan, Jessica B Long, Rong Wang, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Leukemia & Lymphoma
|
April 22, 2024
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with <i>FLT3-</i>mutant acute myeloid leukemia
Jan Philipp Bewersdorf, Kishan K Patel, Rory M Shallis, et al.
Cancer Medicine
|
September 13, 2023
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia
Nikolai A Podoltsev, Rong Wang, Rory M Shallis, et al.
Pharmacology Research & Perspectives
|
November 2, 2024
Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy
Scott F Huntington, Dee Lin, Marie-Hélène Lafeuille, et al.
Leukemia & Lymphoma
|
May 2, 2024
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
Scott F Huntington, Wendy Y Cheng, Eric M Sarpong, et al.
Blood Advances
|
April 21, 2020
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, et al.
Blood Advances
|
July 28, 2025
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML
Abdulrahman Alhajahjeh, Kishan Patel, Nikolai A Podoltsev, et al.
JAMA Network Open
|
June 5, 2023
The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021
Gaurav Goyal, Krystal W Lau, Xiaoliang Wang, et al.
British Journal of Haematology
|
September 22, 2016
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes
Amer M Zeidan, Amy J Davidoff, Jessica B Long, et al.
Leukemia & Lymphoma
|
July 12, 2026
Treatment inequity among older adults with newly diagnosed acute myeloid leukemia ineligible for intensive therapy
Alain Mina, Yanqing Xu, Tatyana A Kapustyan, et al.
Plos One
|
September 14, 2017
Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study
Amer M Zeidan, Jessica B Long, Rong Wang, et al.
Page
of 9